Published in Pediatr Nephrol on August 26, 2006
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19
Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol (2008) 2.64
Rituximab in refractory nephrotic syndrome. Pediatr Nephrol (2009) 1.51
Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis. Clin J Am Soc Nephrol (2009) 1.21
Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant (2013) 1.13
Disease recurrence in paediatric renal transplantation. Pediatr Nephrol (2009) 1.10
Nephrotic syndrome and rituximab: facts and perspectives. Pediatr Nephrol (2009) 1.01
The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review. J Transplant (2011) 0.97
Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab. J Transplant (2011) 0.90
Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible? Pediatr Nephrol (2007) 0.83
Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis. Pediatr Nephrol (2012) 0.82
Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis. Pediatr Nephrol (2007) 0.81
Monoclonal antibodies for podocytopathies: rationale and clinical responses. Nat Rev Nephrol (2009) 0.79
Update on the treatment of focal segmental glomerulosclerosis in renal transplantation. World J Transplant (2016) 0.78
Indications for use and safety of rituximab in childhood renal diseases. Pediatr Nephrol (2012) 0.77
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) (2001) 2.45
Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol (2005) 2.08
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) (2005) 1.83
B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arthritis Rheum (2005) 1.71
Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med (2006) 1.55
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma. Blood (2000) 1.47
Anti B cell therapy (rituximab) in the treatment of autoimmune diseases. Curr Opin Pharmacol (2004) 1.22
B cell depletion in autoimmune disease. Arthritis Res Ther (2003) 1.03
Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol (1993) 0.99
Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder. Clin Transplant (2003) 0.86
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis (2012) 2.21
Renovascular hypertension in children. Lancet (2008) 2.17
Rituximab in refractory nephrotic syndrome. Pediatr Nephrol (2009) 1.51
Chronic kidney disease in children following lung and heart-lung transplantation. Pediatr Transplant (2008) 1.49
Electronic prescribing reduced prescribing errors in a pediatric renal outpatient clinic. J Pediatr (2007) 1.43
Dense B cell infiltrates in paediatric renal transplant biopsies are predictive of allograft loss. Pediatr Transplant (2008) 1.43
Assuring validity of multisource feedback in a national programme. Arch Dis Child (2010) 1.34
HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol (2009) 1.29
Renal biopsies in children: current practice and audit of outcomes. Nephrol Dial Transplant (2009) 1.19
Biologic therapy in primary systemic vasculitis of the young. Rheumatology (Oxford) (2009) 1.12
Incidence of Deflux® calcification masquerading as distal ureteric calculi on ultrasound. J Pediatr Urol (2012) 1.03
Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol (2002) 1.02
Imaging in the evaluation of renovascular disease. Pediatr Nephrol (2009) 1.02
Mid-aortic syndrome: long-term outcome of 36 children. Pediatr Nephrol (2009) 0.99
Results of surgical treatment for renovascular hypertension in children: 30 year single centre experience. Nephrol Dial Transplant (2009) 0.99
Do classification criteria of Takayasu arteritis misdiagnose children with fibromuscular dysplasia? Pediatr Nephrol (2010) 0.95
Standard dosing of tacrolimus leads to overexposure in pediatric renal transplantation recipients. Pediatr Transplant (2008) 0.93
Pre- and postcaptopril renal scintigraphy as a screening test for renovascular hypertension in children. Pediatr Nephrol (2009) 0.93
Renal transplantation or bladder augmentation first? A comparison of complications and outcomes in children. BJU Int (2007) 0.92
Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion. Pediatr Transplant (2005) 0.92
Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum (2013) 0.91
Middle-term use of Cinacalcet in paediatric dialysis patients. Pediatr Nephrol (2009) 0.89
Vasculitis in children and adolescents: clinical presentation, etiopathogenesis, and treatment. Paediatr Drugs (2009) 0.88
Mycophenolate mofetil treatment in children and adolescents with lupus. Arch Dis Child (2010) 0.88
Republished paper: Assuring validity of multisource feedback in a national programme. Postgrad Med J (2010) 0.88
Gadolinium and nephrogenic systemic fibrosis: time to tighten practice. Pediatr Radiol (2007) 0.87
Successful outcomes with rituximab therapy for refractory childhood systemic lupus erythematosus. Pediatr Nephrol (2006) 0.86
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des Devel Ther (2012) 0.86
Ten-year follow-up of children after acute renal failure from a developing country. Nephrol Dial Transplant (2008) 0.86
Clinico-pathological correlations of congenital and infantile nephrotic syndrome over twenty years. Pediatr Nephrol (2014) 0.86
High prevalence of food sensitisation in young children with liver disease: a clue to food allergy pathogenesis? Pediatr Allergy Immunol (2012) 0.84
Non-viral infections in children after renal transplantation. Pediatr Nephrol (2012) 0.84
Living Donation Has a Greater Impact on Renal Allograft Survival Than HLA Matching in Pediatric Renal Transplant Recipients. Transplantation (2016) 0.82
Treating the causes of paediatric hypertension using non-invasive physiological parameters. Med Hypotheses (2010) 0.81
Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study. Pediatr Nephrol (2013) 0.81
Challenges facing renal transplantation in pediatric patients with lower urinary tract dysfunction. Transplantation (2010) 0.81
Distribution of ABO blood group antibody titers in pediatric patients awaiting renal transplantation: implications for organ allocation policy. Transplantation (2012) 0.80
Clinical significance of isolated v lesions in paediatric renal transplant biopsies: muscular arteries required to refute the diagnosis of acute rejection. Transpl Int (2013) 0.80
Vitamin D deficiency is associated with short stature and may influence blood pressure control in paediatric renal transplant recipients. Pediatr Nephrol (2011) 0.80
Renal blood flow using arterial spin labelling MRI and calculated filtration fraction in healthy adult kidney donors Pre-nephrectomy and post-nephrectomy. Eur Radiol (2015) 0.80
Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled Trial. Transplantation (2015) 0.79
Postnatal investigation of fetal renal disease. Semin Fetal Neonatal Med (2008) 0.79
Steroid preservation: the rationale for continued prescribing. Pediatr Nephrol (2005) 0.79
Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease. J Pediatr (2012) 0.78
Prevalence and complications of chronic kidney disease in paediatric renal transplantation: a K/DOQI perspective. Nephrol Dial Transplant (2009) 0.78
Successful treatment of central nervous system PTLD with rituximab and cranial radiotherapy. Pediatr Nephrol (2013) 0.78
The clinical spectrum of hemolytic uremic syndrome secondary to complement factor H autoantibodies. Clin Nephrol (2015) 0.78
Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation. Transplantation (2017) 0.78
Comparison of parameters of chronic kidney disease following paediatric preemptive versus non-preemptive renal transplantation. Pediatr Transplant (2010) 0.77
Indications for use and safety of rituximab in childhood renal diseases. Pediatr Nephrol (2012) 0.77
Family history of cancer in benign brain tumor subtypes versus gliomas. Front Oncol (2012) 0.77
What is the value of magnetic resonance venography in children before renal transplantation? Pediatr Nephrol (2008) 0.76
UK National Registry Study of Kidney Donation After Circulatory Death for Pediatric Recipients. Transplantation (2017) 0.76
Is laparoscopic donation safe for paediatric recipients?--a study of 85 paediatric recipients comparing open and laparoscopic donor nephrectomy. Nephrol Dial Transplant (2011) 0.76
The vascular phenotype of children with systemic lupus erythematosus. Pediatr Nephrol (2015) 0.75
Should children ever be living kidney donors? Pediatr Transplant (2006) 0.75
Primary hyperoxaluria type 1. Arch Dis Child (2007) 0.75
Can pre-implantation biopsies predict renal allograft function in pediatric renal transplant recipients? Saudi Med J (2015) 0.75
Differences between paediatric and adult presentation of ESKD in attainment of adult social goals. Pediatr Nephrol (2014) 0.75
Evaluation of renal improvement in juvenile systemic lupus erythematosus: Comment on the articles by Ruperto et al. Arthritis Rheum (2006) 0.75
Interventions for impaired bladders in paediatric renal transplant recipients with lower urinary tract dysfunction. Transpl Int (2013) 0.75
Estimation of individual sensitivity to cyclosporin in children awaiting renal transplantation. Nephrol Dial Transplant (2003) 0.75
Pediatric transplantation: ten years on. Pediatr Transplant (2009) 0.75
The deletion polymorphism of the ACE gene is not an independent risk factor for renal scarring in children with vesico-ureteric reflux. Nephrol Dial Transplant (2002) 0.75
Incidence and Outcome of C4d Staining With Tubulointerstitial Inflammation in Blood Group-incompatible Kidney Transplantation. Transplantation (2015) 0.75
UK Renal Registry 19th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2015. Nephron (2017) 0.75
Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data. Pediatr Nephrol (2008) 0.75
Insights in Transplanting Complex Paediatric Renal Recipients With Vascular Anomalies. Transplantation (2017) 0.75
Maximising living donation with paediatric blood-group-incompatible renal transplantation. Pediatr Nephrol (2012) 0.75
The views of paediatric specialist registrars on the annual record of in-training assessments. Med Educ (2003) 0.75
Induction therapy: why, when, and which agent? Pediatr Transplant (2010) 0.75
Tacrolimus toxicity secondary to diarrhoea in nephrotic syndrome. Acta Paediatr (2013) 0.75